A SUCCESSFUL TREATMENT OF ERLOTINIB-INDUCED (EPDS) WITH DOXYCYCLINE
Dr. Hammam Ghareep, Dr. Haidar Ghareep*, Professor Dr. Fouz Hasan
ABSTRACT
Cutaneous toxicities are the most common side effects associated with the EGFRi: Erlotinib, occurring in most patients receiving the drug. Clear treatment strategies are therefore necessary to ensure the prevention and optimal management of Erlotinib-related skin toxicities therapy enabling patients to continue Erlotinib treatment. In this case we present a practical approach for (EPDS and acneiform rash) related to Erlotinib, in a patient with non-small cell lung cancer.
Keywords: Cutaneous toxicities are the most common side effects associated with the EGFRi: Erlotinib, occurring in most patients receiving the drug.
[Full Text Article]
[Download Certificate]